BACKGROUND: Multi-tier copayment designs in pharmacy benefit plans are intended to steer patients and prescribers to preferred drug therapies that have lower out-of-pocket costs for patients.
• Surveys of California physicians document that, in 3-tier formulary benefit plans, patients' potential out-of-pocket cost savings may often go unrealized because a majority of physicians (62%-70%) reported never or seldom having knowledge of a patient's out-of-pocket expenses.
• Physicians tend to depend on pharmacists either to communicate patients' medication preferences or to help patients manage out-of-pocket medication costs. In a survey of physician leaders in California, 68% of respondents agreed that it was the pharmacist's responsibility to identify nonpreferred medications.
• In a survey of California Medical Association members, 53% and 33% of respondents reported being familiar most or all of the time with patients' insurers and preferred formulary options, respectively.
What is already known about this subject

What this study adds
• A vast majority (82%) of the physicians in this study believed that it was important to prescribe the drug that would lower total costs, and 94% believed that it was important to prescribe a medication that would reduce patients' copayments. However, only 33% of the physicians believed that it was their responsibility to prescribe preferred medications.
• Physician knowledge of a patient's prescription copayment varies from region to region; 53% of California physicians reported being always or often aware of a patient's insurer, compared with only 35% of physicians in Minnesota and North Dakota.
• Physician specialty was associated with awareness of the identity of the patient's insurer (generalists, 41.1% vs. specialists, 19.2%, P = 0.001) and use of a personal digital assistant (PDA) when prescribing (generalists, 38.9% vs. specialists, 21.1%, P < 0.001).
T he percentage of the health care budget spent on medications is a growing concern in the United States. 1 To constrain prescription drug costs, health plans have instituted incentive-based, tiered copayment pharmacy benefit plans. [2] [3] [4] The Medicare Modernization Act (MMA) calls for the implementation of tiered pharmacy benefit plans that lower patient payments for prescriptions filled with preferred drugs. 3 In recent years, both the percentage of Americans enrolled in multi-tier copayment plans and the financial incentives in these pharmacy benefit plans have increased considerably. 5, 6 As of 2005, 70% of covered workers were enrolled in 3-tier copayment plans, compared with only 8% in 1998. Copayments or out-ofpocket costs for nonpreferred drugs have increased substantially in the last few years from averages of $25 in 2002 to $35 in 2005. 5, 6 Studies of 3-tier formulary benefit plans suggest that patients' out-of-pocket cost savings often go unrealized because many physicians lack the knowledge to help patients minimize their prescription copayments. [2] [3] [4] Researchers also have evaluated the impact of higher prescription drug costs on medication compliance. Higher copayments and lack of prescription drug coverage have been associated with decreased patient medication compliance in some studies, and research suggests that physicians often lack the time to address issues related to copayment and subsequent medication noncompliance at the time of prescribing. [7] [8] [9] [10] [11] [12] [13] [14] [15] For example, using a statistical model based on a cross-sectional analysis of claims data for patients who initiated cholesterollowering therapy, Goldman et al. reported that, for each $10 increase in copayment, average compliance in a plan year was predicted to drop 5 percentage points. 13 Zhang et al. reported the results of a cross-sectional study of angiotensin system blockers, finding that each dollar of additional out-of-pocket cost for a 30-day supply of the initial prescription was associated with a 1.9% increase in the total number of days without therapy.
14 However, some studies have indicated that compliance is unrelated to copayment increases. [15] [16] [17] [18] [19] Specifically, studies using strong er quasi-experimental designs found no relationship between chronic medication adherence and modest ($5-$13) copayment increases. [15] [16] [17] [18] [19] Numerous barriers exist to decreasing prescription copayments by increasing the use of preferred medications on multitier drug formularies. Most notable include the complexities of dealing with multiple drug plans and the time required of physicians and pharmacists to change a prescription to a plan's preferred drug. 7, 11, 20 Little is known about the challenges that physicians face when prescribing in regions where numerous prescription benefit plans provide coverage with multi-tier copayments. Recent studies conducted in California indicate that physicians lack the knowledge to help patients manage their prescription copayments and often depend on pharmacists to serve as the patient's financial advocate. 2, 3 However, these studies may not represent physician prescribing experience in other states because of differences in the prescribing environment. For example, a study of physicians practicing in California may understate the challenges of prescribing in a multi-tier formulary environment because staff-model health maintenance organizations (HMOs) comprise a substantial market share in California, and these physicians are subject to only 1 drug formulary. 4 Also, the concentration of market share in a few HMOs may limit the number of competing formularies. Shrank et al. reported that 40% of responding physicians in California indicated that they prescribe from 0 to 1 formularies. 3 Additionally, Shrank et al. (2005 and documented that, in 3-tier formulary benefit plans, patients' potential out-of-pocket cost savings may often go unrealized because many physicians (62%-70%) reported never or seldom having knowledge of a patient's out-of-pocket expenses. 2, 3 The present study was conducted to describe and assess physician prescribing experiences in a prescribing environment different than in California. Physicians in 2 Midwestern states with patients enrolled in numerous multi-tier copayment formulary plans were surveyed. The survey also included questions about Medicare Part D, because the MMA promoted tiered pharmacy benefit plans 3 in which patient copayments are lower for preferred than for nonpreferred drugs.
Minnesota and North Dakota are upper Midwestern states. In 2006, the majority (72%) of the population in Minnesota resided in urban areas, whereas in North Dakota, a majority (53%) resided in rural areas. 21, 22 Other pertinent information about Minnesota and North Dakota is included in Table 1 . 23 To achieve the objective of this study, we collected information about physicians' beliefs or opinions on prescribing and drug costs, the challenges that physicians face when prescribing in a multi-tier formulary environment, and their use of information technology. (Figure 1 ). Surveys were mailed out between March and May 2006. Nonresponders received up to 2 additional mailed surveys. Follow-up post card reminders were mailed approximately 2 weeks after the first and second survey mailings. Approximately 2 weeks after the last survey mailing, nonresponders were contacted by phone, and we sent an additional survey if requested. Phone surveys were conducted for physicians who indicated this preference. The study was approved by the North Dakota State University Institutional Review Board.
Physicians' Opinions About Responsibility for Patient Out-of-Pocket Costs and Formulary Prescribing in Two Midwestern States
Survey Design
The survey was adapted from an instrument developed by Shrank et al. 2, 3 This modified instrument was pilot tested on 7 practicing physicians in Minnesota and North Dakota, and the survey was refined based on their responses. Major differences between this modified instrument and the instrument used by Shrank et al. 3 included the addition of open-ended comment items and questions about (a) Medicare Part D, (b) knowledge of the national average price of the top 10 selling drugs, and (c) exposure to cost-effective prescribing in medical school and residency training. The final survey consisted of 43 items dealing with physicians' opinions (beliefs) about prescribing and drug costs. Other questions included practice specialty, sources used for drug information, perceived importance of cost containment actions (e.g., prescribing drug with lowest total cost, prescribing drug that minimizes patient out-of-pocket cost), and how often the physician was personally aware of the following when writing a prescription: identity of the patient's insurer, patient's pharmacy benefit structure, preferred medications on the patient's formulary, patient copayment responsibility, and list price of the medication. Survey responses specific to Medicare Part D have been published as a separate manuscript and are not included in this article. 24 The survey included openended, multiple-choice, and 5-point Likert scale questions. A complete copy of the survey is available upon request to the corresponding author.
Data Analysis
Descriptive statistics were used to present the characteristics of the respondents and the primary variables of interest. Physicians whose medical specialties were emergency medicine, family practice (including geriatric), general practice, gynecology, internal medicine (including geriatric), obstetrics and gynecology, obstetrics, and pediatrics were considered to be generalists. Physicians reporting any other medical specialties were considered to be specialists.
The primary variables of interest were physicians' beliefs or opinions about prescribing and drug costs, awareness of patients' prescription copayments at the time of prescribing, awareness of the determinants of those costs (e.g., insurers, formularies, pharmacy benefit structures) and use of information technology. Pearson chi-square analyses were performed to assess associations between outcome measures and independent variables using SAS version 9.1 (SAS Institute Inc., Cary, NC). Statistical significance was set at P < 0.05. We also ascertained the internal consistency (reliability) of the survey instrument for all the questions that included a Likert scale response, using Cronbach's alpha.
Of note, the study sample was a stratified random sample in that 5.1% of the Minnesota and 25.6% of the North Dakota medical association members were selected for study. This design was used to ensure adequate representation from both states.
To ascertain the possible effect of this sampling design on study results, we performed a comparison of Minnesota and North Dakota physicians on key outcome variables. These key outcome variables were (a) importance of prescribing the drug that will minimize patients' out-of-pocket cost, (b) importance of prescribing the drug with the lowest total cost, (c) perceived responsibility to prescribe preferred medications, (d) awareness of the preferred medications on the insurer's formulary, (e) identity or name of the patient's insurer, and (f) use of personal digital assistant (PDA) or computer order entry at the time of prescribing.
■■ Results Survey Response
Of 690 total surveys mailed, 1 was returned from a nonphysician and 42 others were determined to have wrong addresses. Additionally, 36 addresses from nonresponding physicians were deleted because phone numbers were not available and the physicians could not be contacted. A total of 17 respondents were deleted from the denominator because these physicians either did not make any decisions about prescription drugs (n = 11) or no longer practiced medicine (n = 6). The final sampling frame included 594 physicians (Figure 2 ). The overall response rate, including 2 phone surveys, was 49.8% (296 of 594), including 172 of 384 (44.8%) physicians from Minnesota, 123 of 210 (58.6%) physicians from North Dakota, and 1 physician who did not indicate the state in which he or she practiced medicine.
Characteristics of respondents are shown in Table 2 . The age and sex of responding physicians in this sample were similar to national averages. 25 Of 284 respondents who reported the number of formularies from which they prescribe, 34 (12.0%) reported prescribing from 0 to 1 formularies, 56 (19.7%) from 2 to 5 formularies, 74 (26.1%) from 6 or more formularies, and 120 (42.3%) from an unknown number of formularies.
Physicians' Opinions About Prescribing, Drug Costs, and Prescribing Challenges
According to the survey, 82% of the responding physicians agreed that it was important to prescribe the drug with the lowest total cost (Table 3) . Although an overwhelming majority (93.5%) of physicians believed that it was their responsibility to prescribe drugs that would minimize their patients' copayments, only 33 .3% believed that it was their responsibility to prescribe preferred formulary medications.
More than one-third (35.4%) of the physicians indicated that they were often or always aware of the identity of their patient's insurer. However, fewer physicians indicated awareness of list price for the medication (25.8%), the preferred medications on the insurer's formulary (11.9%), the patient's pharmacy benefit structure (9.9%), or the required prescription copayments (12.2%). When asked how often they used various technologies when prescribing, 29.3% of respondents reported using a handheld device or PDA, 22.4% reported using the Internet, and 35.9% reported using handbooks or printed materials often or always (Table 3) . When asked in binary fashion (yes/no) whether they use a PDA or computer order entry when prescribing, 33.9% of respondents reported using a PDA and 39.3% reported using computer order entry (Table 2) . Internal consistency (reliability) among all Likert scale-type responses was considered good (Cronbach's alpha = 0.82).
The mean number of prescriptions written per day among surveyed physicians was 22 (SD 17.8, data not shown). According to the survey, 89% of physicians reported being contacted in a typical day of practice to change a prescription from a nonformulary or nonpreferred drug to a formulary or preferred drug. Furthermore, physicians reported receiving, on average, 2.7 contacts per day (an estimated 12.2% of daily prescriptions) from a pharmacist or patient to change the prescription from a nonpreferred to a preferred drug. Two-thirds of physicians reported that prescriptions were changed to the preferred drugs in these instances. Only 16.7% of the physicians (n = 48) provided comments about formulary compliance. Reported challenges included time spent by physicians taking calls from patients or pharmacists (n = 5), lack of reimbursement for this time spent (n = 4), difficulty in retrieving up-to-date formulary information (n = 11), lack of formulary information (n = 16), and formulary organization not by diagnosis (n = 1). Table 4 contains descriptive information for key outcome variables (opinions about responsibility to minimize patient out-of-pocket cost and total cost, awareness of formulary medications, and perceived responsibility to prescribe formulary medications) and predictor variables, including demographics and use of information technology. Female physicians were more often aware (17.4%) of the preferred medication on a patient's insurer's formulary than were male physicians (9.3%, P = 0.048). Physicians not using a PDA when prescribing were more likely to agree that it was important to prescribe the drug with the lowest total cost than were physicians who used a PDA (85.5% vs. 74.5%, P = 0.023). With that exception, use of information technology, including PDA, Internet, and computer order entry, was not significantly related to any of the key outcome measures. The percentages of physicians reporting awareness of the medications on a patient's formulary were 13.3% and 11.6% for those who answered "yes" when asked whether they use a PDA or computer order entry, respectively; 13.6% for those who reported using the Internet often or always; and 13.6% for those not using any information technology (comparison of those using ≥ 1 vs. 0 tech nologies P = 0.477). Physician specialty (generalist vs. specialist) also was not related significantly to any of the key outcome measures.
Physicians' Opinions About Prescribing, Demographics, and Information Technology Use
Physician Specialty
Statistically significant differences between physician specialty and other variables are reported in Table 5 . Generalists were more often aware of the patient's insurer than were specialists (41.1% vs. 19.2%, P < 0.001), more often used a PDA when writing a prescription (38.9% vs. 21.1%, P = 0.005) and more frequently reported being introduced to cost-effective prescribing during residency training (49.8% vs. 33.8%, P = 0.018). Conversely, when writing prescriptions specialists were more likely than generalists to report using the Internet or handbooks often or always (Internet: 33.3% vs. 18.1%, respectively, P = 0.006; handbooks: 45.6% vs. 32.2%, respectively, P = 0.035).
Physician and Practice Characteristics
Of the comparisons between Minnesota physicians versus North Dakota physicians on key outcome variables, only 1 was statistically significant. Use of computerized order entry at the time of prescribing was more common in Minnesota (47.3%) than in North Dakota (28.3%, P = 0.001).
■■ Discussion
Our findings have implications for patients, physicians, and health plans. A vast majority of the physicians in this study believed that it was important to prescribe the drug that would lower total costs as well as patients' copayments. However, only a minority of physicians believed that it was their responsibility to prescribe preferred medications.
Physicians' opinions about prescribing and drug costs as reported in our study were similar to results of previous studies conducted with physicians in California. [2] [3] [4] However, compared with the California studies, a higher percentage of physicians in our study were generally unaware of determinants of a patient's prescription copayments. This lack of awareness might make prescribing in 3-tier formulary environments even more challeng ing. [2] [3] [4] In our study, 35% and 12% of physicians reported being often or always aware of a patient's insurer and preferred formulary options, respectively. In the California study, 53% and 33% of physicians reported being familiar most or all of the time with the patient's insurer and preferred formulary options, respectively. 3 Several factors could contribute to this finding. First, physicians in our study prescribed from more formularies. (9) 3.4% (10) 93.5% (273) It is important for me to discuss out-of-pocket medication costs with my patients. (n = 291) 8.2% (24) 18.6% (54) 73.2% (213) It is important for me to discuss total costs of medications (not just out-of-pocket costs) with my patients. Only 12% of physicians in the present study reported prescribing from 0 to 1 formularies, 19% reported prescribing from 2 to 5 formularies, and 26% reported prescribing from 6 or more formularies (Figure 3) . 3 In California, where staff-model HMOs comprise a substantial market share, a larger percentage of physicians (40%) reported prescribing from 0 to 1 formularies; 14% of the California study physicians reported prescribing from 2 to 5 formularies, and 19% reported prescribing from 6 or more formularies. 4 Second, it is possible that variables not measured in previous research [2] [3] [4] or in the present study (e.g., frequency of insurance provider changes or formulary updates) may have influenced awareness of patients' insurers and preferred formulary options.
Distribution of Physician Responses to Survey Items
Our survey data are consistent with Shrank et al.'s data in several respects. 2, 3 Specifically, in the present study, generalists were more aware of a patient's formulary than were specialists. Shrank et al. reported that generalists were twice as likely as specialists to report familiarity with patients' formularies. 2 Similarly, we found that generalists were more likely than specialists to report that they were aware of the identity of the patient's insurer. Additionally, 60%-70% of physicians in both surveys reported that they never or rarely are aware of a patient's required prescription copayment despite a majority (91% in Shrank et al., 94% in the present study) agreeing that it was important to prescribe drugs that would minimize copayments. It appears that more effective strategies to close the gap between prescribers' stated desire to minimize patient copayments and the ability do so are needed.
Prescribing from multiple formularies will likely make it more challenging for physicians to be aware of patient prescription copayments because of differences among drug plans. Our findings support the premise that physicians practicing in different parts of the country face a variety of challenges while prescribing in a multi-tier formulary environment. Consequently, a larger, more representative nationwide study to determine the challenges physicians may face when prescribing in environments with multi-tiered drug benefit plans would be useful.
Eighty-nine percent of the physicians reported being contacted in a typical day of practice to change a prescription from a nonformulary or nonpreferred drug to a formulary or preferred drug. Pharmacists play a key role in lowering prescription copayments for patients with multi-tier copayment plans. 2, 3, [26] [27] [28] However, a pharmacist's role in this process needs to be re evaluated in terms of the nationwide pharmacist shortage, which is more severe in rural areas. [29] [30] [31] [32] Paying pharmacists for time spent calling physicians to request a change in prescription to a more cost-effective drug has been proposed. Whether this strategy significantly increases the use of more cost-effective medication requires further study. 33, 34 Limitations Our study has several limitations. First, this study reflects the perceptions of members of the Minnesota Medical Association and the North Dakota Medical Association, who may not represent physicians who practice elsewhere. Second, we do not know the opinions of about half of the recipients of the survey who did not respond, and we have no information about these nonrespondents. However, we note that a study conducted by Shrank et al. 3 using a similar survey instrument had a nearly identical response rate (49.6%), and a telephone follow-up of nonresponders determined that the nonresponders and responders were similar.
Third, as with any survey, our findings may be subject to a nonresponse and social desirability response bias. In particular, the wording of both the survey introduction ("challenges you may be facing with Medicare Part D") and the heading of the survey section that was the source of most of the items reported here ("prescribing challenges") may have encouraged responses from physicians experiencing prescribing difficulties, especially with Medicare Part D. 
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■■ Conclusion
Although surveyed physicians believed that it was important to prescribe drugs that would minimize patients' prescription copayments and total drug costs, they were often unaware of the details needed to enable them to do so. Making this information more available to physicians has the potential to increase prescribing of medications with lower copayments and to increase patient access to needed medications.
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